PATENT CLAIM ANALYSIS

Application Number: 15883055
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "183000"]

Abstract:
Phthalazinediones that function as intracellular redox modulators in the redox therapy of certain stressed cells are provided. By buffering aberrant redox states, phthalazinediones enable cellular processes essential for survival and augment medical treatments. The phthalazinediones of the invention can modulate functions related to cell growth, differentiation, activity, or death, to correct aberrations and restore homeostasis, and can serve as adjunctive therapy in treating various disease conditions.

Claim (Index 10):
The method of  claim 5 , wherein the pharmaceutical composition is administered to the subject in a dose comprising the N-ethanoyl-5-amino-2,3-dihydrophthalazine-1,4-dione in an amount of about 1.0 mg per day to about 10,000.0 mg per day.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.33929
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11199394', '12025193', '12709108', '13764365', '14615704']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7976307050246599
- 35 USC 102 Novelty (BERT): 0.5377043934668172
- Combined Prediction Score: 0.7716380738688756
- Mean Citation Score: 355.13245199999994
- Max Citation Score: 387.61838
- Similarity Product: 278.5956046728575

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test